Breaking News Instant updates and real-time market news.

MRNS

Marinus Pharmaceuticals

$10.71 /

-1.29 (-10.75%)

06:05
09/25/20
09/25
06:05
09/25/20
06:05

Marinus Pharmaceuticals price target raised to $26 from $7 at JMP Securities

JMP Securities analyst Jason Butler raised the firm's price target on Marinus Pharmaceuticals to $26 from $7 and keeps an Outperform rating on the shares. The analyst cites the company's update on the progress with the planned Phase 3 trial for I.V. ganaxolone for refractory status epilepticus in the RAISE trial, whereby based on the positive feedback from the FDA, the company expects to enroll the first patient in October and announce top-line results in the first half of 2022.

  • 17

    Nov

  • 11

    Dec

  • 29

    May

MRNS Marinus Pharmaceuticals
$10.71 /

-1.29 (-10.75%)

09/23/20 Oppenheimer
Marinus Pharmaceuticals price target raised to $28 from $7 at Oppenheimer
09/15/20 SVB Leerink
First indication looking good for Marinus' Ganaxolone, says SVB Leerink
09/15/20 Oppenheimer
Marinus Pharmaceuticals price target raised to $7 from $6 at Oppenheimer
09/15/20 Cantor Fitzgerald
Marinus Pharmaceuticals price target raised to $8 from $6 at Cantor Fitzgerald

TODAY'S FREE FLY STORIES

Hot Stocks
Pinterest reports Q3 global MAUs up 37% to 442M » 16:04
10/28/20
10/28
16:04
10/28/20
16:04
PINS

Pinterest

$49.17 /

-3.41 (-6.49%)

Reports Q3 adj. EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$49.17 /

-3.41 (-6.49%)

PINS Pinterest
$49.17 /

-3.41 (-6.49%)

10/26/20 JPMorgan
Pinterest price target raised to $57 from $37 at JPMorgan
10/26/20 KeyBanc
Pinterest price target raised to $60 from $44 at KeyBanc
10/22/20 OTR Global
Pinterest upgraded to Positive from Mixed at OTR Global
10/21/20
Fly Intel: Top five analyst upgrades
PINS Pinterest
$49.17 /

-3.41 (-6.49%)

PINS Pinterest
$49.17 /

-3.41 (-6.49%)

PINS Pinterest
$49.17 /

-3.41 (-6.49%)

PINS Pinterest
$49.17 /

-3.41 (-6.49%)

Earnings
Sprouts Farmers Market reports Q3 adj. EPS 52c, consensus 36c » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
SFM

Sprouts Farmers Market

$20.37 /

-0.04 (-0.20%)

Reports Q3 revenue $1.6B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

10/20/20
Fly Intel: Top five analyst downgrades
10/20/20 Gordon Haskett
Sprouts Farmers Market downgraded to Hold from Buy at Gordon Haskett
08/06/20 Credit Suisse
Sprouts Farmers Market assumed with a Neutral at Credit Suisse
07/30/20
Fly Intel: Top five analyst initiations
SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

Earnings
Gilead sees core business gradually recovering in Q4 and into 1H21 » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
GILD

Gilead

$58.96 /

-1.065 (-1.77%)

The COVID-19 pandemic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$58.96 /

-1.065 (-1.77%)

GILD Gilead
$58.96 /

-1.065 (-1.77%)

06:28 Today UBS
Gilead initiated with a Neutral at UBS
10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
GILD Gilead
$58.96 /

-1.065 (-1.77%)

GILD Gilead
$58.96 /

-1.065 (-1.77%)

GILD Gilead
$58.96 /

-1.065 (-1.77%)

GILD Gilead
$58.96 /

-1.065 (-1.77%)

Hot Stocks
Amgen sees FY20 share repurchases at lower end of $3B-$5B range  16:03
10/28/20
10/28
16:03
10/28/20
16:03
AMGN

Amgen

$217.70 /

-5.69 (-2.55%)

 
ShowHide Related Items >><<
AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

06:22 Today UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

Earnings
Pinterest reports Q3 EPS 13c, consensus 2c » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
PINS

Pinterest

$49.13 /

-3.45 (-6.56%)

Reports Q3 revenue $443M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$49.13 /

-3.45 (-6.56%)

PINS Pinterest
$49.13 /

-3.45 (-6.56%)

10/26/20 JPMorgan
Pinterest price target raised to $57 from $37 at JPMorgan
10/26/20 KeyBanc
Pinterest price target raised to $60 from $44 at KeyBanc
10/22/20 OTR Global
Pinterest upgraded to Positive from Mixed at OTR Global
10/21/20
Fly Intel: Top five analyst upgrades
PINS Pinterest
$49.13 /

-3.45 (-6.56%)

PINS Pinterest
$49.13 /

-3.45 (-6.56%)

PINS Pinterest
$49.13 /

-3.45 (-6.56%)

PINS Pinterest
$49.13 /

-3.45 (-6.56%)

Earnings
Gilead narrows FY20 adjusted EPS view to $6.25-$6.60 from $6.25-$7.65 » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
GILD

Gilead

$58.95 /

-1.07 (-1.78%)

Consensus $6.98. Narrows…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

06:28 Today UBS
Gilead initiated with a Neutral at UBS
10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

Earnings
Amgen raises FY20 adjusted EPS view to $15.80-$16.15 from $15.10-$15.75 » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
AMGN

Amgen

$217.45 /

-5.94 (-2.66%)

FY20 consensus $15.77.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

06:22 Today UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

Earnings
Cognizant reports Q3 adjusted EPS 97c, consensus 90c » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
CTSH

Cognizant

$71.40 /

-1.97 (-2.69%)

Reports Q3 revenue $4.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

10/13/20 Susquehanna
Cognizant upgraded to Positive at Susquehanna
10/13/20 Susquehanna
Cognizant upgraded to Positive from Neutral at Susquehanna
09/11/20
Fly Intel: Top five analyst upgrades
09/11/20 BofA
Cognizant upgraded to Buy from Neutral at BofA
CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

Earnings
Cognizant reports Q3 adjusted EPS 97c, consensus 90c » 16:02
10/28/20
10/28
16:02
10/28/20
16:02
CTSH

Cognizant

$71.40 /

-1.97 (-2.69%)

Reports Q3 revenue $4.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

10/13/20 Susquehanna
Cognizant upgraded to Positive at Susquehanna
10/13/20 Susquehanna
Cognizant upgraded to Positive from Neutral at Susquehanna
09/11/20
Fly Intel: Top five analyst upgrades
09/11/20 BofA
Cognizant upgraded to Buy from Neutral at BofA
CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

Earnings
Gilead Sciences reports Q3 adjusted EPS $2.11, consensus $1.95 » 16:02
10/28/20
10/28
16:02
10/28/20
16:02
GILD

Gilead

$58.95 /

-1.07 (-1.78%)

Reports Q3 revenue $6.6B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

06:28 Today UBS
Gilead initiated with a Neutral at UBS
10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

Earnings
NIC Inc. expects to be above high end of prior 2020 guidance » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
EGOV

NIC Inc.

$21.07 /

+0.06 (+0.29%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EGOV NIC Inc.
$21.07 /

+0.06 (+0.29%)

12:31 Today DA Davidson
NIC Inc. upgraded to Buy on increased confidence in outlook at DA Davidson
12:26 Today DA Davidson
NIC Inc. upgraded to Buy from Neutral at DA Davidson
04/27/20 Barrington
NIC Inc. price target raised to $30 from $26 at Barrington
04/09/20 DA Davidson
NIC Inc. downgraded to Neutral from Buy at DA Davidson
EGOV NIC Inc.
$21.07 /

+0.06 (+0.29%)

EGOV NIC Inc.
$21.07 /

+0.06 (+0.29%)

Earnings
Amgen reports Q3 adjusted EPS $4.37, consensus $3.80 » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
AMGN

Amgen

$217.77 /

-5.62 (-2.52%)

Reports Q3 revenue $6.4B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

06:22 Today UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

Earnings
Amgen reports Q3 adjusted EPS $4.37, consensus $3.80 » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
AMGN

Amgen

$217.77 /

-5.62 (-2.52%)

Reports Q3 revenue $6.4B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

06:22 Today UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

Earnings
Central Valley Community reports Q3 EPS 35c, consensus 33c » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
CVCY

Central Valley Community

$13.06 /

-0.62 (-4.53%)

"Our financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVCY Central Valley Community
$13.06 /

-0.62 (-4.53%)

CVCY Central Valley Community
$13.06 /

-0.62 (-4.53%)

10/13/20 Piper Sandler
Central Valley Community price target lowered to $15 from $17 at Piper Sandler
09/08/20 Janney Montgomery Scott
Janney Montgomery Scott upgrades Central Valley Community to Buy after selloff
09/08/20 Janney Montgomery Scott
Central Valley Community upgraded to Buy from Neutral at Janney Montgomery Scott
04/16/20
DA Davidson upgrades Central Valley Community to Buy on resilient NIM
CVCY Central Valley Community
$13.06 /

-0.62 (-4.53%)

Downgrade
Concho Resources downgraded to Sector Perform from Outperform at Scotiabank » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
CXO

Concho Resources

$41.58 /

-2.1 (-4.81%)

Scotiabank analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

10/23/20 Stephens
Concho Resources cut to Equal Weight after ConocoPhillips deal at Stephens
10/23/20 Stephens
Concho Resources downgraded to Equal Weight from Overweight at Stephens
10/21/20 Morgan Stanley
Cimarex, Diamondback could benefit from greater scale, says Morgan Stanley
10/21/20 US Capital Advisors
Concho Resources downgraded to Hold from Buy at US Capital Advisors
CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

Earnings
NIC Inc. reports Q3 EPS 37c, consensus 21c » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
EGOV

NIC Inc.

$21.09 /

+0.08 (+0.38%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EGOV NIC Inc.
$21.09 /

+0.08 (+0.38%)

12:31 Today DA Davidson
NIC Inc. upgraded to Buy on increased confidence in outlook at DA Davidson
12:26 Today DA Davidson
NIC Inc. upgraded to Buy from Neutral at DA Davidson
04/27/20 Barrington
NIC Inc. price target raised to $30 from $26 at Barrington
04/09/20 DA Davidson
NIC Inc. downgraded to Neutral from Buy at DA Davidson
EGOV NIC Inc.
$21.09 /

+0.08 (+0.38%)

EGOV NIC Inc.
$21.09 /

+0.08 (+0.38%)

On The Fly
#SocialStocks: Facebook, Twitter focus on election as votes start coming in » 15:55
10/28/20
10/28
15:55
10/28/20
15:55
FB

Facebook

$270.31 /

-12.98 (-4.58%)

, TWTR

Twitter

$49.10 /

-2.185 (-4.26%)

, GOOG

Alphabet

$1,527.75 /

-76.87 (-4.79%)

, GOOGL

Alphabet Class A

$1,520.00 /

-79.75 (-4.99%)

, ORCL

Oracle

$55.83 /

-1.255 (-2.20%)

, WMT

Walmart

$141.02 /

-1.81 (-1.27%)

, SQ

Square

$168.03 /

-2.88 (-1.69%)

Welcome to…

ShowHide Related Items >><<
FB Facebook
$270.31 /

-12.98 (-4.58%)

TWTR Twitter
$49.10 /

-2.185 (-4.26%)

GOOG Alphabet
$1,527.75 /

-76.87 (-4.79%)

GOOGL Alphabet Class A
$1,520.00 /

-79.75 (-4.99%)

ORCL Oracle
$55.83 /

-1.255 (-2.20%)

WMT Walmart
$141.02 /

-1.81 (-1.27%)

SQ Square
$168.03 /

-2.88 (-1.69%)

FB Facebook
$270.31 /

-12.98 (-4.58%)

08:31 Today JPMorgan
Facebook price target raised to $315 from $300 at JPMorgan
10/26/20 KeyBanc
Facebook price target raised to $340 from $330 at KeyBanc
10/26/20 Mizuho
Facebook price target raised to $330 from $315 at Mizuho
10/22/20 Argus
Snap price target raised to $50 from $30 at Argus
TWTR Twitter
$49.10 /

-2.185 (-4.26%)

10/27/20 BofA
Twitter price target raised to $58 from $52 at BofA
10/27/20 JPMorgan
Twitter price target raised to $52 from $39 at JPMorgan
10/26/20 Wedbush
Twitter price target raised to $47 from $37.50 at Wedbush
10/26/20 Mizuho
Twitter price target raised to $45 from $40 at Mizuho
GOOG Alphabet
$1,527.75 /

-76.87 (-4.79%)

10/23/20 Cleveland Research
Alphabet upgraded to Buy on Search, Cloud momentum at Cleveland Research
10/22/20 Jefferies
Jefferies says 71% of Google users would still use search if removed from device
10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
GOOGL Alphabet Class A
$1,520.00 /

-79.75 (-4.99%)

10/23/20 Cleveland Research
Alphabet upgraded to Buy on Search, Cloud momentum at Cleveland Research
10/23/20 Cleveland Research
Alphabet Class A upgraded to Buy from Neutral at Cleveland Research
10/22/20 Jefferies
Jefferies says 71% of Google users would still use search if removed from device
10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
ORCL Oracle
$55.83 /

-1.255 (-2.20%)

10/23/20 Barclays
Oracle price target raised to $62 from $59 at Barclays
10/13/20 UBS
Oracle assumed with a Neutral at UBS
09/22/20 Morgan Stanley
Morgan Stanley says hard to tell if TikTok deal true 'thesis-changer' for Oracle
09/21/20
Fly Intel: Top five analyst upgrades
WMT Walmart
$141.02 /

-1.81 (-1.27%)

10/23/20 Evercore ISI
Kroger downgraded to In Line from Outperform at Evercore ISI
10/20/20 Stephens
Keeping Sam's Club a 'nice win' for Synchrony, says Stephens
10/15/20 Jefferies
Walmart assumed with a Buy at Jefferies
10/13/20 Bernstein
Bernstein downgrades Beyond Meat to Underperform on 'stretched' valuation
SQ Square
$168.03 /

-2.88 (-1.69%)

10/27/20 Deutsche Bank
Square price target raised to $215 from $180 at Deutsche Bank
10/22/20 Mizuho
Square selloff on 'double whammy' a buying opportunity, says Mizuho
10/21/20 Barclays
Square price target raised to $215 from $185 at Barclays
10/16/20 RBC Capital
Square price target raised to $240 from $200 at RBC Capital
FB Facebook
$270.31 /

-12.98 (-4.58%)

TWTR Twitter
$49.10 /

-2.185 (-4.26%)

GOOG Alphabet
$1,527.75 /

-76.87 (-4.79%)

GOOGL Alphabet Class A
$1,520.00 /

-79.75 (-4.99%)

ORCL Oracle
$55.83 /

-1.255 (-2.20%)

WMT Walmart
$141.02 /

-1.81 (-1.27%)

SQ Square
$168.03 /

-2.88 (-1.69%)

FB Facebook
$270.31 /

-12.98 (-4.58%)

TWTR Twitter
$49.10 /

-2.185 (-4.26%)

GOOG Alphabet
$1,527.75 /

-76.87 (-4.79%)

GOOGL Alphabet Class A
$1,520.00 /

-79.75 (-4.99%)

ORCL Oracle
$55.83 /

-1.255 (-2.20%)

WMT Walmart
$141.02 /

-1.81 (-1.27%)

SQ Square
$168.03 /

-2.88 (-1.69%)

FB Facebook
$270.31 /

-12.98 (-4.58%)

TWTR Twitter
$49.10 /

-2.185 (-4.26%)

GOOG Alphabet
$1,527.75 /

-76.87 (-4.79%)

GOOGL Alphabet Class A
$1,520.00 /

-79.75 (-4.99%)

ORCL Oracle
$55.83 /

-1.255 (-2.20%)

WMT Walmart
$141.02 /

-1.81 (-1.27%)

SQ Square
$168.03 /

-2.88 (-1.69%)

FB Facebook
$270.31 /

-12.98 (-4.58%)

TWTR Twitter
$49.10 /

-2.185 (-4.26%)

GOOGL Alphabet Class A
$1,520.00 /

-79.75 (-4.99%)

ORCL Oracle
$55.83 /

-1.255 (-2.20%)

WMT Walmart
$141.02 /

-1.81 (-1.27%)

SQ Square
$168.03 /

-2.88 (-1.69%)

GOOGL Alphabet Class A
$1,520.00 /

-79.75 (-4.99%)

Options
T Mobile put volume heavy and directionally bearish » 15:55
10/28/20
10/28
15:55
10/28/20
15:55
TMUS

T-Mobile

$110.63 /

-2.22 (-1.97%)

Bearish flow noted in T…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TMUS T-Mobile
$110.63 /

-2.22 (-1.97%)

TMUS T-Mobile
$110.63 /

-2.22 (-1.97%)

10/16/20
Fly Intel: Top five analyst initiations
10/16/20 Evercore ISI
T-Mobile resumed with an Outperform at Evercore ISI
10/14/20 Jefferies
Apple price target raised to $140 from $135 at Jefferies
10/14/20 Citi
T-Mobile price target raised to $142 from $130 at Citi
TMUS T-Mobile
$110.63 /

-2.22 (-1.97%)

  • 24
    Jun
TMUS T-Mobile
$110.63 /

-2.22 (-1.97%)

TMUS T-Mobile
$110.63 /

-2.22 (-1.97%)

TMUS T-Mobile
$110.63 /

-2.22 (-1.97%)

Conference/Events
UBS Asia tech analysts to hold analyst/industry conference call » 15:55
10/28/20
10/28
15:55
10/28/20
15:55

Asia Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
UMB Financial upgraded to Buy at BofA after earnings » 15:49
10/28/20
10/28
15:49
10/28/20
15:49
UMBF

UMB Financial

$58.91 /

+2.34 (+4.14%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UMBF UMB Financial
$58.91 /

+2.34 (+4.14%)

UMBF UMB Financial
$58.91 /

+2.34 (+4.14%)

15:44 Today BofA
UMB Financial upgraded to Buy from Neutral at BofA
07/30/20 Wells Fargo
UMB Financial upgraded to Equal Weight from Underweight at Wells Fargo
07/13/20 Stephens
UMB Financial named a Best Idea at Stephens
01/06/20 Wells Fargo
UMB Financial downgraded to Underweight on valuation at Wells Fargo
UMBF UMB Financial
$58.91 /

+2.34 (+4.14%)

Options
Cameco call volume above normal and directionally bullish » 15:45
10/28/20
10/28
15:45
10/28/20
15:45
CCJ

Cameco

$9.43 /

-0.16 (-1.67%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCJ Cameco
$9.43 /

-0.16 (-1.67%)

CCJ Cameco
$9.43 /

-0.16 (-1.67%)

08/28/20 GLJ Research
Cameco initiated with a Buy at GLJ Research
07/30/20 RBC Capital
Cameco price target lowered to C$14 from C$15 at RBC Capital
05/05/20 RBC Capital
Cameco price target raised to C$15 from C$14 at RBC Capital
05/05/20 BMO Capital
Cameco price target raised to C$16 from C$12 at BMO Capital
CCJ Cameco
$9.43 /

-0.16 (-1.67%)

CCJ Cameco
$9.43 /

-0.16 (-1.67%)

Upgrade
UMB Financial upgraded to Buy from Neutral at BofA » 15:44
10/28/20
10/28
15:44
10/28/20
15:44
UMBF

UMB Financial

$58.74 /

+2.17 (+3.84%)

BofA upgraded UMB…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UMBF UMB Financial
$58.74 /

+2.17 (+3.84%)

UMBF UMB Financial
$58.74 /

+2.17 (+3.84%)

07/30/20 Wells Fargo
UMB Financial upgraded to Equal Weight from Underweight at Wells Fargo
07/13/20 Stephens
UMB Financial named a Best Idea at Stephens
01/06/20 Wells Fargo
UMB Financial downgraded to Underweight on valuation at Wells Fargo
01/06/20 Wells Fargo
UMB Financial downgraded to Underweight from Equal Weight at Wells Fargo
UMBF UMB Financial
$58.74 /

+2.17 (+3.84%)

Hot Stocks
Cerner reports total backlog $13.01B  15:36
10/28/20
10/28
15:36
10/28/20
15:36
CERN

Cerner

$71.10 /

-1.64 (-2.25%)

 
ShowHide Related Items >><<
CERN Cerner
$71.10 /

-1.64 (-2.25%)

CERN Cerner
$71.10 /

-1.64 (-2.25%)

07/31/20 Deutsche Bank
Cerner price target raised to $77 from $72 at Deutsche Bank
07/06/20 Stephens
Cerner initiated with an Equal Weight at Stephens
06/15/20 Evercore ISI
Cerner assumed with an In Line at Evercore ISI
06/10/20 Lake Street
OptimizeRx news strategically significant, broadens reach, says Lake Street
CERN Cerner
$71.10 /

-1.64 (-2.25%)

CERN Cerner
$71.10 /

-1.64 (-2.25%)

CERN Cerner
$71.10 /

-1.64 (-2.25%)

Earnings
Cerner sees Q4 adjusted EPS 76c-80c, consensus 78c » 15:35
10/28/20
10/28
15:35
10/28/20
15:35
CERN

Cerner

$71.10 /

-1.64 (-2.25%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CERN Cerner
$71.10 /

-1.64 (-2.25%)

CERN Cerner
$71.10 /

-1.64 (-2.25%)

07/31/20 Deutsche Bank
Cerner price target raised to $77 from $72 at Deutsche Bank
07/06/20 Stephens
Cerner initiated with an Equal Weight at Stephens
06/15/20 Evercore ISI
Cerner assumed with an In Line at Evercore ISI
06/10/20 Lake Street
OptimizeRx news strategically significant, broadens reach, says Lake Street
CERN Cerner
$71.10 /

-1.64 (-2.25%)

CERN Cerner
$71.10 /

-1.64 (-2.25%)

CERN Cerner
$71.10 /

-1.64 (-2.25%)

Options
Sunnova Energy options imply 20.0% move in share price post-earnings » 15:34
10/28/20
10/28
15:34
10/28/20
15:34
NOVA

Sunnova Energy

$26.60 /

+0.3 (+1.14%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NOVA Sunnova Energy
$26.60 /

+0.3 (+1.14%)

NOVA Sunnova Energy
$26.60 /

+0.3 (+1.14%)

10/27/20 B. Riley Securities
Sunnova Energy price target raised to $33 from $30 at B. Riley Securities
10/26/20 Credit Suisse
Sunnova Energy price target raised to $38 from $26 at Credit Suisse
10/22/20 Baird
Baird a buyer of solar stocks insulated from supply chain disruptions
10/14/20 JMP Securities
Sunnova Energy price target raised to $55 from $43 at JMP Securities
NOVA Sunnova Energy
$26.60 /

+0.3 (+1.14%)

  • 14
    Aug
  • 01
    Jul
NOVA Sunnova Energy
$26.60 /

+0.3 (+1.14%)

NOVA Sunnova Energy
$26.60 /

+0.3 (+1.14%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.